Extensions for Using Data Elements from FHIR DSTU2 in FHIR R4B
0.1.0 - STU
Extensions for Using Data Elements from FHIR DSTU2 in FHIR R4B
0.1.0 - STU
Extensions for Using Data Elements from FHIR DSTU2 in FHIR R4B - Downloaded Version null See the Directory of published versions
| Page standards status: Trial-use | Maturity Level: 0 |
<CodeSystem xmlns="http://hl7.org/fhir">
<id value="v2-0292"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: CodeSystem v2-0292</b></p><a name="v2-0292"> </a><a name="hcv2-0292"> </a><p><b>Properties</b></p><p><b>This code system defines the following properties for its concepts</b></p><table class="grid"><tr><td><b>Name</b></td><td><b>Code</b></td><td><b>URI</b></td><td><b>Type</b></td></tr><tr><td>status</td><td>status</td><td>http://hl7.org/fhir/concept-properties#status</td><td>code</td></tr><tr><td>Inactive</td><td>inactive</td><td>http://hl7.org/fhir/concept-properties#inactive</td><td>boolean</td></tr><tr><td>effectiveDate</td><td>effectiveDate</td><td>http://hl7.org/fhir/concept-properties#effectiveDate</td><td>dateTime</td></tr><tr><td>deprecationDate</td><td>deprecationDate</td><td>http://hl7.org/fhir/concept-properties#deprecationDate</td><td>dateTime</td></tr><tr><td>retirementDate</td><td>retirementDate</td><td>http://hl7.org/fhir/concept-properties#retirementDate</td><td>dateTime</td></tr><tr><td>Not Selectable</td><td>notSelectable</td><td>http://hl7.org/fhir/concept-properties#notSelectable</td><td>boolean</td></tr><tr><td>Parent</td><td>parent</td><td>http://hl7.org/fhir/concept-properties#parent</td><td>code</td></tr><tr><td>Child</td><td>child</td><td>http://hl7.org/fhir/concept-properties#child</td><td>code</td></tr><tr><td>partOf</td><td>partOf</td><td>http://hl7.org/fhir/concept-properties#partOf</td><td>code</td></tr><tr><td>synonym</td><td>synonym</td><td>http://hl7.org/fhir/concept-properties#synonym</td><td>code</td></tr><tr><td>comment</td><td>comment</td><td>http://hl7.org/fhir/concept-properties#comment</td><td>string</td></tr><tr><td>itemWeight</td><td>itemWeight</td><td>http://hl7.org/fhir/concept-properties#itemWeight</td><td>decimal</td></tr></table><p><b>Concepts</b></p><p>This case-insensitive code system <code>http://hl7.org/fhir/v2/0292</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Nederlands (Dutch, nl)</b></td></tr><tr><td style="white-space:nowrap">01<a name="v2-0292-01"> </a></td><td>DTP</td><td>DKT - difterie-kinkhoest-tetanus</td></tr><tr><td style="white-space:nowrap">02<a name="v2-0292-02"> </a></td><td>OPV</td><td>OPV</td></tr><tr><td style="white-space:nowrap">03<a name="v2-0292-03"> </a></td><td>MMR</td><td>BMR - mazelen, bof, rodehond</td></tr><tr><td style="white-space:nowrap">04<a name="v2-0292-04"> </a></td><td>M/R</td><td>M/R</td></tr><tr><td style="white-space:nowrap">05<a name="v2-0292-05"> </a></td><td>measles</td><td>mazelen</td></tr><tr><td style="white-space:nowrap">06<a name="v2-0292-06"> </a></td><td>rubella</td><td>rodehond</td></tr><tr><td style="white-space:nowrap">07<a name="v2-0292-07"> </a></td><td>mumps</td><td>bof</td></tr><tr><td style="white-space:nowrap">08<a name="v2-0292-08"> </a></td><td>Hep B, adolescent or pediatric</td><td>Hep B, adolescent of pediatrie</td></tr><tr><td style="white-space:nowrap">09<a name="v2-0292-09"> </a></td><td>Td (adult)</td><td>DT - difterie en tetanus (volwassene)</td></tr><tr><td style="white-space:nowrap">10<a name="v2-0292-10"> </a></td><td>IPV</td><td>IPV</td></tr><tr><td style="white-space:nowrap">100<a name="v2-0292-100"> </a></td><td>pneumococcal conjugate</td><td>pneumokokken conjugaat</td></tr><tr><td style="white-space:nowrap">101<a name="v2-0292-101"> </a></td><td>typhoid, ViCPs</td><td>tyfus, ViCPs</td></tr><tr><td style="white-space:nowrap">102<a name="v2-0292-102"> </a></td><td>DTP-Hib-Hep B</td><td>DKT-Hib-Hep B</td></tr><tr><td style="white-space:nowrap">103<a name="v2-0292-103"> </a></td><td>meningococcal C conjugate</td><td>meningokokken C conjugaat</td></tr><tr><td style="white-space:nowrap">104<a name="v2-0292-104"> </a></td><td>Hep A-Hep B</td><td>Hep A-Hep B</td></tr><tr><td style="white-space:nowrap">105<a name="v2-0292-105"> </a></td><td>vaccinia (smallpox) diluted</td><td>vaccinia (pokken) verzwakt</td></tr><tr><td style="white-space:nowrap">106<a name="v2-0292-106"> </a></td><td>DTaP, 5 pertussis antigens6</td><td>DaKT, 5 kinkhoest antigenen6</td></tr><tr><td style="white-space:nowrap">107<a name="v2-0292-107"> </a></td><td>DTaP, NOS</td><td>DaKT, niet anders gespecificeerd</td></tr><tr><td style="white-space:nowrap">108<a name="v2-0292-108"> </a></td><td>meningococcal, NOS</td><td>meningokokken, niet anders gespecificeerd</td></tr><tr><td style="white-space:nowrap">109<a name="v2-0292-109"> </a></td><td>pneumococcal, NOS</td><td>pneumokokken, niet anders gespecificeerd</td></tr><tr><td style="white-space:nowrap">11<a name="v2-0292-11"> </a></td><td>pertussis</td><td>kinkhoest</td></tr><tr><td style="white-space:nowrap">110<a name="v2-0292-110"> </a></td><td>DTaP-Hep B-IPV</td><td>DaKT-Hep B-IPV</td></tr><tr><td style="white-space:nowrap">111<a name="v2-0292-111"> </a></td><td>influenza, live, intranasal</td><td>influenza, levend, intranasaal</td></tr><tr><td style="white-space:nowrap">112<a name="v2-0292-112"> </a></td><td>tetanus toxoid, NOS</td><td>tetanus toxoïde, niet anders gespecificeerd</td></tr><tr><td style="white-space:nowrap">113<a name="v2-0292-113"> </a></td><td>Td (adult)</td><td>DT - difterie en tetanus (volwassene)</td></tr><tr><td style="white-space:nowrap">114<a name="v2-0292-114"> </a></td><td>meningococcal A,C,Y,W-135 diphtheria conjugate</td><td>meningokokken A,C,Y,W-135 difterie conjugaat</td></tr><tr><td style="white-space:nowrap">115<a name="v2-0292-115"> </a></td><td>Tdap</td><td>tetanus toxoïde, verminderde difterie toxoïde, en acellulaire kinkhoest</td></tr><tr><td style="white-space:nowrap">116<a name="v2-0292-116"> </a></td><td>rotavirus, pentavalent</td><td>rotavirus, pentavalent</td></tr><tr><td style="white-space:nowrap">117<a name="v2-0292-117"> </a></td><td>VZIG (IND)</td><td>VZIG (IND)</td></tr><tr><td style="white-space:nowrap">118<a name="v2-0292-118"> </a></td><td>HPV, bivalent</td><td>HPV, bivalent</td></tr><tr><td style="white-space:nowrap">119<a name="v2-0292-119"> </a></td><td>rotavirus, monovalent</td><td>rotavirus, monovalent</td></tr><tr><td style="white-space:nowrap">12<a name="v2-0292-12"> </a></td><td>diphtheria antitoxin</td><td>difterie antitoxine</td></tr><tr><td style="white-space:nowrap">120<a name="v2-0292-120"> </a></td><td>DTaP-Hib-IPV</td><td>DaKT-Hib-IPV</td></tr><tr><td style="white-space:nowrap">121<a name="v2-0292-121"> </a></td><td>zoster</td><td>gordelroos</td></tr><tr><td style="white-space:nowrap">122<a name="v2-0292-122"> </a></td><td>rotavirus, NOS1</td><td>rotavirus, niet anders gespecificeerd1</td></tr><tr><td style="white-space:nowrap">13<a name="v2-0292-13"> </a></td><td>TIG</td><td>TIG</td></tr><tr><td style="white-space:nowrap">14<a name="v2-0292-14"> </a></td><td>IG, NOS</td><td>IG, niet anders gespecificeerd</td></tr><tr><td style="white-space:nowrap">15<a name="v2-0292-15"> </a></td><td>influenza, split (incl. purified surface antigen)</td><td>influenza, gesplitst (incl. gezuiverd oppervlakte antigen)</td></tr><tr><td style="white-space:nowrap">16<a name="v2-0292-16"> </a></td><td>influenza, whole</td><td>influenza, geheel</td></tr><tr><td style="white-space:nowrap">17<a name="v2-0292-17"> </a></td><td>Hib, NOS</td><td>Hib, niet anders gespecificeerd</td></tr><tr><td style="white-space:nowrap">18<a name="v2-0292-18"> </a></td><td>rabies, intramuscular injection</td><td>hondsdolheid, intramusculaire injectie</td></tr><tr><td style="white-space:nowrap">19<a name="v2-0292-19"> </a></td><td>BCG</td><td>BCG</td></tr><tr><td style="white-space:nowrap">20<a name="v2-0292-20"> </a></td><td>DTaP</td><td>DaKT</td></tr><tr><td style="white-space:nowrap">21<a name="v2-0292-21"> </a></td><td>varicella</td><td>varicella</td></tr><tr><td style="white-space:nowrap">22<a name="v2-0292-22"> </a></td><td>DTP-Hib</td><td>DKT-Hib</td></tr><tr><td style="white-space:nowrap">23<a name="v2-0292-23"> </a></td><td>plague</td><td>pest</td></tr><tr><td style="white-space:nowrap">24<a name="v2-0292-24"> </a></td><td>anthrax</td><td>miltvuur</td></tr><tr><td style="white-space:nowrap">25<a name="v2-0292-25"> </a></td><td>typhoid, oral</td><td>tyfus, oral</td></tr><tr><td style="white-space:nowrap">26<a name="v2-0292-26"> </a></td><td>cholera</td><td>cholera</td></tr><tr><td style="white-space:nowrap">27<a name="v2-0292-27"> </a></td><td>botulinum antitoxin</td><td>botulisme antitoxine</td></tr><tr><td style="white-space:nowrap">28<a name="v2-0292-28"> </a></td><td>DT (pediatric)</td><td>DT - difterie-tetanus (pediatrie)</td></tr><tr><td style="white-space:nowrap">29<a name="v2-0292-29"> </a></td><td>CMVIG</td><td>CMVIG</td></tr><tr><td style="white-space:nowrap">30<a name="v2-0292-30"> </a></td><td>HBIG</td><td>HBIG</td></tr><tr><td style="white-space:nowrap">31<a name="v2-0292-31"> </a></td><td>Hep A, pediatric, NOS</td><td>Hep A, pediatrie, niet anders gespecificeerd</td></tr><tr><td style="white-space:nowrap">32<a name="v2-0292-32"> </a></td><td>meningococcal</td><td>meningokokken</td></tr><tr><td style="white-space:nowrap">33<a name="v2-0292-33"> </a></td><td>pneumococcal</td><td>pneumokokken</td></tr><tr><td style="white-space:nowrap">34<a name="v2-0292-34"> </a></td><td>RIG</td><td>hondsdolheid immunoglobuline</td></tr><tr><td style="white-space:nowrap">35<a name="v2-0292-35"> </a></td><td>tetanus toxoid</td><td>tetanus toxoïde</td></tr><tr><td style="white-space:nowrap">36<a name="v2-0292-36"> </a></td><td>VZIG</td><td>VZIG</td></tr><tr><td style="white-space:nowrap">37<a name="v2-0292-37"> </a></td><td>yellow fever</td><td>gele koorts</td></tr><tr><td style="white-space:nowrap">38<a name="v2-0292-38"> </a></td><td>rubella/mumps</td><td>rodehond/bof</td></tr><tr><td style="white-space:nowrap">39<a name="v2-0292-39"> </a></td><td>Japanese encephalitis</td><td>Japanse encefalitis</td></tr><tr><td style="white-space:nowrap">40<a name="v2-0292-40"> </a></td><td>rabies, intradermal injection</td><td>hondsdolheid, intradermale injectie</td></tr><tr><td style="white-space:nowrap">41<a name="v2-0292-41"> </a></td><td>typhoid, parenteral</td><td>tyfus, parenteraal</td></tr><tr><td style="white-space:nowrap">42<a name="v2-0292-42"> </a></td><td>Hep B, adolescent/high risk infant2</td><td>Hep B, adolescent/hoogrisico zuigeling2</td></tr><tr><td style="white-space:nowrap">43<a name="v2-0292-43"> </a></td><td>Hep B, adult4</td><td>Hep B, volwassen4</td></tr><tr><td style="white-space:nowrap">44<a name="v2-0292-44"> </a></td><td>Hep B, dialysis</td><td>Hep B, dialyse</td></tr><tr><td style="white-space:nowrap">45<a name="v2-0292-45"> </a></td><td>Hep B, NOS</td><td>Hep B, niet anders gespecificeerd</td></tr><tr><td style="white-space:nowrap">46<a name="v2-0292-46"> </a></td><td>Hib (PRP-D)</td><td>Hib (PRP-D)</td></tr><tr><td style="white-space:nowrap">47<a name="v2-0292-47"> </a></td><td>Hib (HbOC)</td><td>Hib (HbOC)</td></tr><tr><td style="white-space:nowrap">48<a name="v2-0292-48"> </a></td><td>Hib (PRP-T)</td><td>Hib (PRP-T)</td></tr><tr><td style="white-space:nowrap">49<a name="v2-0292-49"> </a></td><td>Hib (PRP-OMP)</td><td>Hib (PRP-OMP)</td></tr><tr><td style="white-space:nowrap">50<a name="v2-0292-50"> </a></td><td>DTaP-Hib</td><td>DaKT-Hib</td></tr><tr><td style="white-space:nowrap">51<a name="v2-0292-51"> </a></td><td>Hib-Hep B</td><td>Hib-Hep B</td></tr><tr><td style="white-space:nowrap">52<a name="v2-0292-52"> </a></td><td>Hep A, adult</td><td>Hep A, volwassene</td></tr><tr><td style="white-space:nowrap">53<a name="v2-0292-53"> </a></td><td>typhoid, parenteral, AKD (U.S. military)</td><td>tyfus, parenteraal, AKD (Amerikaanse leger)</td></tr><tr><td style="white-space:nowrap">54<a name="v2-0292-54"> </a></td><td>adenovirus, type 4</td><td>adenovirus, type 4</td></tr><tr><td style="white-space:nowrap">55<a name="v2-0292-55"> </a></td><td>adenovirus, type 7</td><td>adenovirus, type 7</td></tr><tr><td style="white-space:nowrap">56<a name="v2-0292-56"> </a></td><td>dengue fever</td><td>knokkelkoorts</td></tr><tr><td style="white-space:nowrap">57<a name="v2-0292-57"> </a></td><td>hantavirus</td><td>hantavirus</td></tr><tr><td style="white-space:nowrap">58<a name="v2-0292-58"> </a></td><td>Hep C</td><td>Hep C</td></tr><tr><td style="white-space:nowrap">59<a name="v2-0292-59"> </a></td><td>Hep E</td><td>Hep E</td></tr><tr><td style="white-space:nowrap">60<a name="v2-0292-60"> </a></td><td>herpes simplex 2</td><td>herpes simplex 2</td></tr><tr><td style="white-space:nowrap">61<a name="v2-0292-61"> </a></td><td>HIV</td><td>HIV</td></tr><tr><td style="white-space:nowrap">62<a name="v2-0292-62"> </a></td><td>HPV, quadrivalent</td><td>HPV, quadrivalent</td></tr><tr><td style="white-space:nowrap">63<a name="v2-0292-63"> </a></td><td>Junin virus</td><td>Junín virus</td></tr><tr><td style="white-space:nowrap">64<a name="v2-0292-64"> </a></td><td>leishmaniasis</td><td>leishmaniase</td></tr><tr><td style="white-space:nowrap">65<a name="v2-0292-65"> </a></td><td>leprosy</td><td>leprosy</td></tr><tr><td style="white-space:nowrap">66<a name="v2-0292-66"> </a></td><td>Lyme disease</td><td>ziekte van Lyme</td></tr><tr><td style="white-space:nowrap">67<a name="v2-0292-67"> </a></td><td>malaria</td><td>malaria</td></tr><tr><td style="white-space:nowrap">68<a name="v2-0292-68"> </a></td><td>melanoma</td><td>melanoom</td></tr><tr><td style="white-space:nowrap">69<a name="v2-0292-69"> </a></td><td>parainfluenza-3</td><td>parainfluenza-3</td></tr><tr><td style="white-space:nowrap">70<a name="v2-0292-70"> </a></td><td>Q fever</td><td>Q-koorts</td></tr><tr><td style="white-space:nowrap">71<a name="v2-0292-71"> </a></td><td>RSV-IGIV</td><td>RSV-IGIV</td></tr><tr><td style="white-space:nowrap">72<a name="v2-0292-72"> </a></td><td>rheumatic fever</td><td>reumatische koorts</td></tr><tr><td style="white-space:nowrap">73<a name="v2-0292-73"> </a></td><td>Rift Valley fever</td><td>Riftdalkoorts</td></tr><tr><td style="white-space:nowrap">74<a name="v2-0292-74"> </a></td><td>rotavirus, tetravalent</td><td>rotavirus, tetravalent</td></tr><tr><td style="white-space:nowrap">75<a name="v2-0292-75"> </a></td><td>vaccinia (smallpox)</td><td>vaccinia (pokken)</td></tr><tr><td style="white-space:nowrap">76<a name="v2-0292-76"> </a></td><td>Staphylococcus bacterio lysate</td><td>Staphylococcus bacterio lysate</td></tr><tr><td style="white-space:nowrap">77<a name="v2-0292-77"> </a></td><td>tick-borne encephalitis</td><td>frühsommer-meningoenzephalitis vaccin</td></tr><tr><td style="white-space:nowrap">78<a name="v2-0292-78"> </a></td><td>tularemia vaccine</td><td>tularemia vaccin</td></tr><tr><td style="white-space:nowrap">79<a name="v2-0292-79"> </a></td><td>vaccinia immune globulin</td><td>vaccinia immunoglobuline</td></tr><tr><td style="white-space:nowrap">80<a name="v2-0292-80"> </a></td><td>VEE, live</td><td>VEE, levend</td></tr><tr><td style="white-space:nowrap">81<a name="v2-0292-81"> </a></td><td>VEE, inactivated</td><td>VEE, inactief</td></tr><tr><td style="white-space:nowrap">82<a name="v2-0292-82"> </a></td><td>adenovirus, NOS1</td><td>adenovirus, niet anders gespecificeerd1</td></tr><tr><td style="white-space:nowrap">83<a name="v2-0292-83"> </a></td><td>Hep A, ped/adol, 2 dose</td><td>Hep A, ped/adol, 2 dosis</td></tr><tr><td style="white-space:nowrap">84<a name="v2-0292-84"> </a></td><td>Hep A, ped/adol, 3 dose</td><td>Hep A, ped/adol, 3 dosis</td></tr><tr><td style="white-space:nowrap">85<a name="v2-0292-85"> </a></td><td>Hep A, NOS</td><td>Hep A, niet anders gespecificeerd</td></tr><tr><td style="white-space:nowrap">86<a name="v2-0292-86"> </a></td><td>IG</td><td>IG</td></tr><tr><td style="white-space:nowrap">87<a name="v2-0292-87"> </a></td><td>IGIV</td><td>IGIV</td></tr><tr><td style="white-space:nowrap">88<a name="v2-0292-88"> </a></td><td>influenza, NOS</td><td>influenza, niet anders gespecificeerd</td></tr><tr><td style="white-space:nowrap">89<a name="v2-0292-89"> </a></td><td>polio, NOS</td><td>polio, niet anders gespecificeerd</td></tr><tr><td style="white-space:nowrap">90<a name="v2-0292-90"> </a></td><td>rabies, NOS</td><td>hondsdolheid, niet anders gespecificeerd</td></tr><tr><td style="white-space:nowrap">91<a name="v2-0292-91"> </a></td><td>typhoid, NOS</td><td>tyfus, niet anders gespecificeerd</td></tr><tr><td style="white-space:nowrap">92<a name="v2-0292-92"> </a></td><td>VEE, NOS</td><td>VEE, niet anders gespecificeerd</td></tr><tr><td style="white-space:nowrap">93<a name="v2-0292-93"> </a></td><td>RSV-MAb</td><td>RSV-MAb</td></tr><tr><td style="white-space:nowrap">94<a name="v2-0292-94"> </a></td><td>MMRV</td><td>BMRV - mazelen, bof, rodehond en varicella</td></tr><tr><td style="white-space:nowrap">95<a name="v2-0292-95"> </a></td><td>TST-OT tine test</td><td>TST-OT tine test</td></tr><tr><td style="white-space:nowrap">96<a name="v2-0292-96"> </a></td><td>TST-PPD intradermal</td><td>TST-PPD intradermal</td></tr><tr><td style="white-space:nowrap">97<a name="v2-0292-97"> </a></td><td>TST-PPD tine test</td><td>TST-PPD tine test</td></tr><tr><td style="white-space:nowrap">98<a name="v2-0292-98"> </a></td><td>TST, NOS</td><td>TST, niet anders gespecificeerd</td></tr><tr><td style="white-space:nowrap">99<a name="v2-0292-99"> </a></td><td>RESERVED - do not use3</td><td>GERESERVEERD - niet gebruiken3</td></tr><tr><td style="white-space:nowrap">998<a name="v2-0292-998"> </a></td><td>no vaccine administered5</td><td>geen vaccin toegediend5</td></tr><tr><td style="white-space:nowrap">999<a name="v2-0292-999"> </a></td><td>unknown</td><td>onbekend</td></tr></table></div>
</text>
<extension url="http://hl7.org/fhir/StructureDefinition/valueset-oid">
<valueUri value="urn:oid:2.16.840.1.133883.18.182"/>
</extension>
<extension url="http://hl7.org/fhir/StructureDefinition/package-source">
<extension url="packageId">
<valueId value="hl7.fhir.uv.xver-r2.r4b"/>
</extension>
<extension url="version">
<valueString value="0.1.0"/>
</extension>
<extension url="uri">
<valueUri
value="http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r2.r4b"/>
</extension>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg">
<valueCode value="fhir"/>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm">
<valueInteger value="0">
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom">
<valueCanonical
value="http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r2.r4b"/>
</extension>
</valueInteger>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status">
<valueCode value="trial-use">
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom">
<valueCanonical
value="http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r2.r4b"/>
</extension>
</valueCode>
</extension>
<url value="http://hl7.org/fhir/v2/0292"/>
<version value="1.0.2"/>
<name value="v2-0292"/>
<status value="draft"/>
<date value="2026-03-20T11:13:27+11:00"/>
<publisher value="FHIR Infrastructure"/>
<contact>
<name value="FHIR Infrastructure"/>
<telecom>
<system value="url"/>
<value value="http://www.hl7.org/Special/committees/fiwg"/>
</telecom>
</contact>
<jurisdiction>
<coding>
<system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/>
<code value="001"/>
<display value="World"/>
</coding>
</jurisdiction>
<caseSensitive value="false"/>
<content value="complete"/>
<property>
<code value="status"/>
<uri value="http://hl7.org/fhir/concept-properties#status"/>
<type value="code"/>
</property>
<property>
<code value="inactive"/>
<uri value="http://hl7.org/fhir/concept-properties#inactive"/>
<type value="boolean"/>
</property>
<property>
<code value="effectiveDate"/>
<uri value="http://hl7.org/fhir/concept-properties#effectiveDate"/>
<type value="dateTime"/>
</property>
<property>
<code value="deprecationDate"/>
<uri value="http://hl7.org/fhir/concept-properties#deprecationDate"/>
<type value="dateTime"/>
</property>
<property>
<code value="retirementDate"/>
<uri value="http://hl7.org/fhir/concept-properties#retirementDate"/>
<type value="dateTime"/>
</property>
<property>
<code value="notSelectable"/>
<uri value="http://hl7.org/fhir/concept-properties#notSelectable"/>
<type value="boolean"/>
</property>
<property>
<code value="parent"/>
<uri value="http://hl7.org/fhir/concept-properties#parent"/>
<type value="code"/>
</property>
<property>
<code value="child"/>
<uri value="http://hl7.org/fhir/concept-properties#child"/>
<type value="code"/>
</property>
<property>
<code value="partOf"/>
<uri value="http://hl7.org/fhir/concept-properties#partOf"/>
<type value="code"/>
</property>
<property>
<code value="synonym"/>
<uri value="http://hl7.org/fhir/concept-properties#synonym"/>
<type value="code"/>
</property>
<property>
<code value="comment"/>
<uri value="http://hl7.org/fhir/concept-properties#comment"/>
<type value="string"/>
</property>
<property>
<code value="itemWeight"/>
<uri value="http://hl7.org/fhir/concept-properties#itemWeight"/>
<type value="decimal"/>
</property>
<concept>
<code value="01"/>
<display value="DTP"/>
<designation>
<language value="nl"/>
<value value="DKT - difterie-kinkhoest-tetanus"/>
</designation>
</concept>
<concept>
<code value="02"/>
<display value="OPV"/>
<designation>
<language value="nl"/>
<value value="OPV"/>
</designation>
</concept>
<concept>
<code value="03"/>
<display value="MMR"/>
<designation>
<language value="nl"/>
<value value="BMR - mazelen, bof, rodehond"/>
</designation>
</concept>
<concept>
<code value="04"/>
<display value="M/R"/>
<designation>
<language value="nl"/>
<value value="M/R"/>
</designation>
</concept>
<concept>
<code value="05"/>
<display value="measles"/>
<designation>
<language value="nl"/>
<value value="mazelen"/>
</designation>
</concept>
<concept>
<code value="06"/>
<display value="rubella"/>
<designation>
<language value="nl"/>
<value value="rodehond"/>
</designation>
</concept>
<concept>
<code value="07"/>
<display value="mumps"/>
<designation>
<language value="nl"/>
<value value="bof"/>
</designation>
</concept>
<concept>
<code value="08"/>
<display value="Hep B, adolescent or pediatric"/>
<designation>
<language value="nl"/>
<value value="Hep B, adolescent of pediatrie"/>
</designation>
</concept>
<concept>
<code value="09"/>
<display value="Td (adult)"/>
<designation>
<language value="nl"/>
<value value="DT - difterie en tetanus (volwassene)"/>
</designation>
</concept>
<concept>
<code value="10"/>
<display value="IPV"/>
<designation>
<language value="nl"/>
<value value="IPV"/>
</designation>
</concept>
<concept>
<code value="100"/>
<display value="pneumococcal conjugate"/>
<designation>
<language value="nl"/>
<value value="pneumokokken conjugaat"/>
</designation>
</concept>
<concept>
<code value="101"/>
<display value="typhoid, ViCPs"/>
<designation>
<language value="nl"/>
<value value="tyfus, ViCPs"/>
</designation>
</concept>
<concept>
<code value="102"/>
<display value="DTP-Hib-Hep B"/>
<designation>
<language value="nl"/>
<value value="DKT-Hib-Hep B"/>
</designation>
</concept>
<concept>
<code value="103"/>
<display value="meningococcal C conjugate"/>
<designation>
<language value="nl"/>
<value value="meningokokken C conjugaat"/>
</designation>
</concept>
<concept>
<code value="104"/>
<display value="Hep A-Hep B"/>
<designation>
<language value="nl"/>
<value value="Hep A-Hep B"/>
</designation>
</concept>
<concept>
<code value="105"/>
<display value="vaccinia (smallpox) diluted"/>
<designation>
<language value="nl"/>
<value value="vaccinia (pokken) verzwakt"/>
</designation>
</concept>
<concept>
<code value="106"/>
<display value="DTaP, 5 pertussis antigens6"/>
<designation>
<language value="nl"/>
<value value="DaKT, 5 kinkhoest antigenen6"/>
</designation>
</concept>
<concept>
<code value="107"/>
<display value="DTaP, NOS"/>
<designation>
<language value="nl"/>
<value value="DaKT, niet anders gespecificeerd"/>
</designation>
</concept>
<concept>
<code value="108"/>
<display value="meningococcal, NOS"/>
<designation>
<language value="nl"/>
<value value="meningokokken, niet anders gespecificeerd"/>
</designation>
</concept>
<concept>
<code value="109"/>
<display value="pneumococcal, NOS"/>
<designation>
<language value="nl"/>
<value value="pneumokokken, niet anders gespecificeerd"/>
</designation>
</concept>
<concept>
<code value="11"/>
<display value="pertussis"/>
<designation>
<language value="nl"/>
<value value="kinkhoest"/>
</designation>
</concept>
<concept>
<code value="110"/>
<display value="DTaP-Hep B-IPV"/>
<designation>
<language value="nl"/>
<value value="DaKT-Hep B-IPV"/>
</designation>
</concept>
<concept>
<code value="111"/>
<display value="influenza, live, intranasal"/>
<designation>
<language value="nl"/>
<value value="influenza, levend, intranasaal"/>
</designation>
</concept>
<concept>
<code value="112"/>
<display value="tetanus toxoid, NOS"/>
<designation>
<language value="nl"/>
<value value="tetanus toxoïde, niet anders gespecificeerd"/>
</designation>
</concept>
<concept>
<code value="113"/>
<display value="Td (adult)"/>
<designation>
<language value="nl"/>
<value value="DT - difterie en tetanus (volwassene)"/>
</designation>
</concept>
<concept>
<code value="114"/>
<display value="meningococcal A,C,Y,W-135 diphtheria conjugate"/>
<designation>
<language value="nl"/>
<value value="meningokokken A,C,Y,W-135 difterie conjugaat"/>
</designation>
</concept>
<concept>
<code value="115"/>
<display value="Tdap"/>
<designation>
<language value="nl"/>
<value
value="tetanus toxoïde, verminderde difterie toxoïde, en acellulaire kinkhoest"/>
</designation>
</concept>
<concept>
<code value="116"/>
<display value="rotavirus, pentavalent"/>
<designation>
<language value="nl"/>
<value value="rotavirus, pentavalent"/>
</designation>
</concept>
<concept>
<code value="117"/>
<display value="VZIG (IND)"/>
<designation>
<language value="nl"/>
<value value="VZIG (IND)"/>
</designation>
</concept>
<concept>
<code value="118"/>
<display value="HPV, bivalent"/>
<designation>
<language value="nl"/>
<value value="HPV, bivalent"/>
</designation>
</concept>
<concept>
<code value="119"/>
<display value="rotavirus, monovalent"/>
<designation>
<language value="nl"/>
<value value="rotavirus, monovalent"/>
</designation>
</concept>
<concept>
<code value="12"/>
<display value="diphtheria antitoxin"/>
<designation>
<language value="nl"/>
<value value="difterie antitoxine"/>
</designation>
</concept>
<concept>
<code value="120"/>
<display value="DTaP-Hib-IPV"/>
<designation>
<language value="nl"/>
<value value="DaKT-Hib-IPV"/>
</designation>
</concept>
<concept>
<code value="121"/>
<display value="zoster"/>
<designation>
<language value="nl"/>
<value value="gordelroos"/>
</designation>
</concept>
<concept>
<code value="122"/>
<display value="rotavirus, NOS1"/>
<designation>
<language value="nl"/>
<value value="rotavirus, niet anders gespecificeerd1"/>
</designation>
</concept>
<concept>
<code value="13"/>
<display value="TIG"/>
<designation>
<language value="nl"/>
<value value="TIG"/>
</designation>
</concept>
<concept>
<code value="14"/>
<display value="IG, NOS"/>
<designation>
<language value="nl"/>
<value value="IG, niet anders gespecificeerd"/>
</designation>
</concept>
<concept>
<code value="15"/>
<display value="influenza, split (incl. purified surface antigen)"/>
<designation>
<language value="nl"/>
<value
value="influenza, gesplitst (incl. gezuiverd oppervlakte antigen)"/>
</designation>
</concept>
<concept>
<code value="16"/>
<display value="influenza, whole"/>
<designation>
<language value="nl"/>
<value value="influenza, geheel"/>
</designation>
</concept>
<concept>
<code value="17"/>
<display value="Hib, NOS"/>
<designation>
<language value="nl"/>
<value value="Hib, niet anders gespecificeerd"/>
</designation>
</concept>
<concept>
<code value="18"/>
<display value="rabies, intramuscular injection"/>
<designation>
<language value="nl"/>
<value value="hondsdolheid, intramusculaire injectie"/>
</designation>
</concept>
<concept>
<code value="19"/>
<display value="BCG"/>
<designation>
<language value="nl"/>
<value value="BCG"/>
</designation>
</concept>
<concept>
<code value="20"/>
<display value="DTaP"/>
<designation>
<language value="nl"/>
<value value="DaKT"/>
</designation>
</concept>
<concept>
<code value="21"/>
<display value="varicella"/>
<designation>
<language value="nl"/>
<value value="varicella"/>
</designation>
</concept>
<concept>
<code value="22"/>
<display value="DTP-Hib"/>
<designation>
<language value="nl"/>
<value value="DKT-Hib"/>
</designation>
</concept>
<concept>
<code value="23"/>
<display value="plague"/>
<designation>
<language value="nl"/>
<value value="pest"/>
</designation>
</concept>
<concept>
<code value="24"/>
<display value="anthrax"/>
<designation>
<language value="nl"/>
<value value="miltvuur"/>
</designation>
</concept>
<concept>
<code value="25"/>
<display value="typhoid, oral"/>
<designation>
<language value="nl"/>
<value value="tyfus, oral"/>
</designation>
</concept>
<concept>
<code value="26"/>
<display value="cholera"/>
<designation>
<language value="nl"/>
<value value="cholera"/>
</designation>
</concept>
<concept>
<code value="27"/>
<display value="botulinum antitoxin"/>
<designation>
<language value="nl"/>
<value value="botulisme antitoxine"/>
</designation>
</concept>
<concept>
<code value="28"/>
<display value="DT (pediatric)"/>
<designation>
<language value="nl"/>
<value value="DT - difterie-tetanus (pediatrie)"/>
</designation>
</concept>
<concept>
<code value="29"/>
<display value="CMVIG"/>
<designation>
<language value="nl"/>
<value value="CMVIG"/>
</designation>
</concept>
<concept>
<code value="30"/>
<display value="HBIG"/>
<designation>
<language value="nl"/>
<value value="HBIG"/>
</designation>
</concept>
<concept>
<code value="31"/>
<display value="Hep A, pediatric, NOS"/>
<designation>
<language value="nl"/>
<value value="Hep A, pediatrie, niet anders gespecificeerd"/>
</designation>
</concept>
<concept>
<code value="32"/>
<display value="meningococcal"/>
<designation>
<language value="nl"/>
<value value="meningokokken"/>
</designation>
</concept>
<concept>
<code value="33"/>
<display value="pneumococcal"/>
<designation>
<language value="nl"/>
<value value="pneumokokken"/>
</designation>
</concept>
<concept>
<code value="34"/>
<display value="RIG"/>
<designation>
<language value="nl"/>
<value value="hondsdolheid immunoglobuline"/>
</designation>
</concept>
<concept>
<code value="35"/>
<display value="tetanus toxoid"/>
<designation>
<language value="nl"/>
<value value="tetanus toxoïde"/>
</designation>
</concept>
<concept>
<code value="36"/>
<display value="VZIG"/>
<designation>
<language value="nl"/>
<value value="VZIG"/>
</designation>
</concept>
<concept>
<code value="37"/>
<display value="yellow fever"/>
<designation>
<language value="nl"/>
<value value="gele koorts"/>
</designation>
</concept>
<concept>
<code value="38"/>
<display value="rubella/mumps"/>
<designation>
<language value="nl"/>
<value value="rodehond/bof"/>
</designation>
</concept>
<concept>
<code value="39"/>
<display value="Japanese encephalitis"/>
<designation>
<language value="nl"/>
<value value="Japanse encefalitis"/>
</designation>
</concept>
<concept>
<code value="40"/>
<display value="rabies, intradermal injection"/>
<designation>
<language value="nl"/>
<value value="hondsdolheid, intradermale injectie"/>
</designation>
</concept>
<concept>
<code value="41"/>
<display value="typhoid, parenteral"/>
<designation>
<language value="nl"/>
<value value="tyfus, parenteraal"/>
</designation>
</concept>
<concept>
<code value="42"/>
<display value="Hep B, adolescent/high risk infant2"/>
<designation>
<language value="nl"/>
<value value="Hep B, adolescent/hoogrisico zuigeling2"/>
</designation>
</concept>
<concept>
<code value="43"/>
<display value="Hep B, adult4"/>
<designation>
<language value="nl"/>
<value value="Hep B, volwassen4"/>
</designation>
</concept>
<concept>
<code value="44"/>
<display value="Hep B, dialysis"/>
<designation>
<language value="nl"/>
<value value="Hep B, dialyse"/>
</designation>
</concept>
<concept>
<code value="45"/>
<display value="Hep B, NOS"/>
<designation>
<language value="nl"/>
<value value="Hep B, niet anders gespecificeerd"/>
</designation>
</concept>
<concept>
<code value="46"/>
<display value="Hib (PRP-D)"/>
<designation>
<language value="nl"/>
<value value="Hib (PRP-D)"/>
</designation>
</concept>
<concept>
<code value="47"/>
<display value="Hib (HbOC)"/>
<designation>
<language value="nl"/>
<value value="Hib (HbOC)"/>
</designation>
</concept>
<concept>
<code value="48"/>
<display value="Hib (PRP-T)"/>
<designation>
<language value="nl"/>
<value value="Hib (PRP-T)"/>
</designation>
</concept>
<concept>
<code value="49"/>
<display value="Hib (PRP-OMP)"/>
<designation>
<language value="nl"/>
<value value="Hib (PRP-OMP)"/>
</designation>
</concept>
<concept>
<code value="50"/>
<display value="DTaP-Hib"/>
<designation>
<language value="nl"/>
<value value="DaKT-Hib"/>
</designation>
</concept>
<concept>
<code value="51"/>
<display value="Hib-Hep B"/>
<designation>
<language value="nl"/>
<value value="Hib-Hep B"/>
</designation>
</concept>
<concept>
<code value="52"/>
<display value="Hep A, adult"/>
<designation>
<language value="nl"/>
<value value="Hep A, volwassene"/>
</designation>
</concept>
<concept>
<code value="53"/>
<display value="typhoid, parenteral, AKD (U.S. military)"/>
<designation>
<language value="nl"/>
<value value="tyfus, parenteraal, AKD (Amerikaanse leger)"/>
</designation>
</concept>
<concept>
<code value="54"/>
<display value="adenovirus, type 4"/>
<designation>
<language value="nl"/>
<value value="adenovirus, type 4"/>
</designation>
</concept>
<concept>
<code value="55"/>
<display value="adenovirus, type 7"/>
<designation>
<language value="nl"/>
<value value="adenovirus, type 7"/>
</designation>
</concept>
<concept>
<code value="56"/>
<display value="dengue fever"/>
<designation>
<language value="nl"/>
<value value="knokkelkoorts"/>
</designation>
</concept>
<concept>
<code value="57"/>
<display value="hantavirus"/>
<designation>
<language value="nl"/>
<value value="hantavirus"/>
</designation>
</concept>
<concept>
<code value="58"/>
<display value="Hep C"/>
<designation>
<language value="nl"/>
<value value="Hep C"/>
</designation>
</concept>
<concept>
<code value="59"/>
<display value="Hep E"/>
<designation>
<language value="nl"/>
<value value="Hep E"/>
</designation>
</concept>
<concept>
<code value="60"/>
<display value="herpes simplex 2"/>
<designation>
<language value="nl"/>
<value value="herpes simplex 2"/>
</designation>
</concept>
<concept>
<code value="61"/>
<display value="HIV"/>
<designation>
<language value="nl"/>
<value value="HIV"/>
</designation>
</concept>
<concept>
<code value="62"/>
<display value="HPV, quadrivalent"/>
<designation>
<language value="nl"/>
<value value="HPV, quadrivalent"/>
</designation>
</concept>
<concept>
<code value="63"/>
<display value="Junin virus"/>
<designation>
<language value="nl"/>
<value value="Junín virus"/>
</designation>
</concept>
<concept>
<code value="64"/>
<display value="leishmaniasis"/>
<designation>
<language value="nl"/>
<value value="leishmaniase"/>
</designation>
</concept>
<concept>
<code value="65"/>
<display value="leprosy"/>
<designation>
<language value="nl"/>
<value value="leprosy"/>
</designation>
</concept>
<concept>
<code value="66"/>
<display value="Lyme disease"/>
<designation>
<language value="nl"/>
<value value="ziekte van Lyme"/>
</designation>
</concept>
<concept>
<code value="67"/>
<display value="malaria"/>
<designation>
<language value="nl"/>
<value value="malaria"/>
</designation>
</concept>
<concept>
<code value="68"/>
<display value="melanoma"/>
<designation>
<language value="nl"/>
<value value="melanoom"/>
</designation>
</concept>
<concept>
<code value="69"/>
<display value="parainfluenza-3"/>
<designation>
<language value="nl"/>
<value value="parainfluenza-3"/>
</designation>
</concept>
<concept>
<code value="70"/>
<display value="Q fever"/>
<designation>
<language value="nl"/>
<value value="Q-koorts"/>
</designation>
</concept>
<concept>
<code value="71"/>
<display value="RSV-IGIV"/>
<designation>
<language value="nl"/>
<value value="RSV-IGIV"/>
</designation>
</concept>
<concept>
<code value="72"/>
<display value="rheumatic fever"/>
<designation>
<language value="nl"/>
<value value="reumatische koorts"/>
</designation>
</concept>
<concept>
<code value="73"/>
<display value="Rift Valley fever"/>
<designation>
<language value="nl"/>
<value value="Riftdalkoorts"/>
</designation>
</concept>
<concept>
<code value="74"/>
<display value="rotavirus, tetravalent"/>
<designation>
<language value="nl"/>
<value value="rotavirus, tetravalent"/>
</designation>
</concept>
<concept>
<code value="75"/>
<display value="vaccinia (smallpox)"/>
<designation>
<language value="nl"/>
<value value="vaccinia (pokken)"/>
</designation>
</concept>
<concept>
<code value="76"/>
<display value="Staphylococcus bacterio lysate"/>
<designation>
<language value="nl"/>
<value value="Staphylococcus bacterio lysate"/>
</designation>
</concept>
<concept>
<code value="77"/>
<display value="tick-borne encephalitis"/>
<designation>
<language value="nl"/>
<value value="frühsommer-meningoenzephalitis vaccin"/>
</designation>
</concept>
<concept>
<code value="78"/>
<display value="tularemia vaccine"/>
<designation>
<language value="nl"/>
<value value="tularemia vaccin"/>
</designation>
</concept>
<concept>
<code value="79"/>
<display value="vaccinia immune globulin"/>
<designation>
<language value="nl"/>
<value value="vaccinia immunoglobuline"/>
</designation>
</concept>
<concept>
<code value="80"/>
<display value="VEE, live"/>
<designation>
<language value="nl"/>
<value value="VEE, levend"/>
</designation>
</concept>
<concept>
<code value="81"/>
<display value="VEE, inactivated"/>
<designation>
<language value="nl"/>
<value value="VEE, inactief"/>
</designation>
</concept>
<concept>
<code value="82"/>
<display value="adenovirus, NOS1"/>
<designation>
<language value="nl"/>
<value value="adenovirus, niet anders gespecificeerd1"/>
</designation>
</concept>
<concept>
<code value="83"/>
<display value="Hep A, ped/adol, 2 dose"/>
<designation>
<language value="nl"/>
<value value="Hep A, ped/adol, 2 dosis"/>
</designation>
</concept>
<concept>
<code value="84"/>
<display value="Hep A, ped/adol, 3 dose"/>
<designation>
<language value="nl"/>
<value value="Hep A, ped/adol, 3 dosis"/>
</designation>
</concept>
<concept>
<code value="85"/>
<display value="Hep A, NOS"/>
<designation>
<language value="nl"/>
<value value="Hep A, niet anders gespecificeerd"/>
</designation>
</concept>
<concept>
<code value="86"/>
<display value="IG"/>
<designation>
<language value="nl"/>
<value value="IG"/>
</designation>
</concept>
<concept>
<code value="87"/>
<display value="IGIV"/>
<designation>
<language value="nl"/>
<value value="IGIV"/>
</designation>
</concept>
<concept>
<code value="88"/>
<display value="influenza, NOS"/>
<designation>
<language value="nl"/>
<value value="influenza, niet anders gespecificeerd"/>
</designation>
</concept>
<concept>
<code value="89"/>
<display value="polio, NOS"/>
<designation>
<language value="nl"/>
<value value="polio, niet anders gespecificeerd"/>
</designation>
</concept>
<concept>
<code value="90"/>
<display value="rabies, NOS"/>
<designation>
<language value="nl"/>
<value value="hondsdolheid, niet anders gespecificeerd"/>
</designation>
</concept>
<concept>
<code value="91"/>
<display value="typhoid, NOS"/>
<designation>
<language value="nl"/>
<value value="tyfus, niet anders gespecificeerd"/>
</designation>
</concept>
<concept>
<code value="92"/>
<display value="VEE, NOS"/>
<designation>
<language value="nl"/>
<value value="VEE, niet anders gespecificeerd"/>
</designation>
</concept>
<concept>
<code value="93"/>
<display value="RSV-MAb"/>
<designation>
<language value="nl"/>
<value value="RSV-MAb"/>
</designation>
</concept>
<concept>
<code value="94"/>
<display value="MMRV"/>
<designation>
<language value="nl"/>
<value value="BMRV - mazelen, bof, rodehond en varicella"/>
</designation>
</concept>
<concept>
<code value="95"/>
<display value="TST-OT tine test"/>
<designation>
<language value="nl"/>
<value value="TST-OT tine test"/>
</designation>
</concept>
<concept>
<code value="96"/>
<display value="TST-PPD intradermal"/>
<designation>
<language value="nl"/>
<value value="TST-PPD intradermal"/>
</designation>
</concept>
<concept>
<code value="97"/>
<display value="TST-PPD tine test"/>
<designation>
<language value="nl"/>
<value value="TST-PPD tine test"/>
</designation>
</concept>
<concept>
<code value="98"/>
<display value="TST, NOS"/>
<designation>
<language value="nl"/>
<value value="TST, niet anders gespecificeerd"/>
</designation>
</concept>
<concept>
<code value="99"/>
<display value="RESERVED - do not use3"/>
<designation>
<language value="nl"/>
<value value="GERESERVEERD - niet gebruiken3"/>
</designation>
</concept>
<concept>
<code value="998"/>
<display value="no vaccine administered5"/>
<designation>
<language value="nl"/>
<value value="geen vaccin toegediend5"/>
</designation>
</concept>
<concept>
<code value="999"/>
<display value="unknown"/>
<designation>
<language value="nl"/>
<value value="onbekend"/>
</designation>
</concept>
</CodeSystem>
IG © 2025+ FHIR Infrastructure. Package hl7.fhir.uv.xver-r2.r4b#0.1.0 based on FHIR 4.3.0. Generated 2026-03-20
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change